Ambroxol soothes the cough and reduces its duration. Prepared on the basis of the Guidelines of the German Society of Pulmonology and Respiratory Diseases for the diagnosis and treatment of adult patients with acute, subacute and chronic cough. From the first day, it greatly facilitates expectoration and significantly reduces the viscosity of the secret. Based on Germout J et al. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trials in 120 patients at two doses of Respiration 51 (Suppl 1), 37-41 (1987), (N = 60, acute and obstructive Atemwegserkrankungen). Ambroxol has a significant effect on sputum viscosity/expectoration from the first day of infection (120 mg ambroxol) (RCT versus placebo n = 60). 2. Mukosolvan Mini, CHPL 05/2017. Mukosolvan® MINI, 15 mg/5 ml, syrup. 5 ml of syrup contains 15 mg of ambroxol hydrochloride (Ambroxoli hydrochloridum). Indications for use: Acute and chronic diseases of the lungs and bronchi with impaired secretion of mucus and difficulty in its transport. Contraindications: hypersensitivity to ambroxol hydrochloride or any of the excipients.
Before use, read the package leaflet containing indications, contraindications, side effects and dosage information, and information about the use of the medicine, or consult a doctor or pharmacist, as every medicine used off-label poses a risk to your life or health.
Buy Mucosolvan Mini
Price Mucosolvan Mini
Цена Mucosolvan Mini
Купить Mucosolvan Mini
AcheterMucosolvan Mini
Prix Mucosolvan Mini
ComprarMucosolvan Mini
Precio Mucosolvan Mini
